Purpose of review In the last years, food allergy treatment is moving away from food avoidance to interventional treatments. We review here the recent developments on immunotherapy with food allergens. Recent findings Oral immunotherapy remains the best studied form of food immunotherapy. In 2017, further evidence has been added to its efficacy. Its mechanisms of action are under scrutiny. To reduce its side effects, studies have been dedicated to the simultaneous use of biologics, in particular omalizumab. Among the other forms of food immunotherapy that are being developed, the epicutaneous application of food allergens is promising. Summary The immunologic trajectories of the development of food tolerance may be intercepted by different forms of food immunotherapy. Research efforts aim to make these therapies feasible at the clinical level.

How to actively treat food allergy / Pecora, V.; Mennini, M.; Calandrelli, V.; Patriarca, G.; Valluzzi, R.; Fierro, V.. - In: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1528-4050. - 18:3(2018), pp. 248-257. [10.1097/ACI.0000000000000450]

How to actively treat food allergy

Mennini M.;
2018

Abstract

Purpose of review In the last years, food allergy treatment is moving away from food avoidance to interventional treatments. We review here the recent developments on immunotherapy with food allergens. Recent findings Oral immunotherapy remains the best studied form of food immunotherapy. In 2017, further evidence has been added to its efficacy. Its mechanisms of action are under scrutiny. To reduce its side effects, studies have been dedicated to the simultaneous use of biologics, in particular omalizumab. Among the other forms of food immunotherapy that are being developed, the epicutaneous application of food allergens is promising. Summary The immunologic trajectories of the development of food tolerance may be intercepted by different forms of food immunotherapy. Research efforts aim to make these therapies feasible at the clinical level.
2018
cow milk allergy; egg allergy; food allergy; omalizumab; oral immunotherapy; peanut allergy; Administration, Oral; Administration, Sublingual; Allergens; Biological Products; Food; Food Hypersensitivity; Humans; Immune Tolerance; Immunoglobulin E; Immunotherapy; Omalizumab; Transdermal Patch
01 Pubblicazione su rivista::01a Articolo in rivista
How to actively treat food allergy / Pecora, V.; Mennini, M.; Calandrelli, V.; Patriarca, G.; Valluzzi, R.; Fierro, V.. - In: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1528-4050. - 18:3(2018), pp. 248-257. [10.1097/ACI.0000000000000450]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1314466
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact